US 10876134
Gene therapy for juvenile batten disease
granted A61KA61K48/00A61P
Quick answer
US patent 10876134 (Gene therapy for juvenile batten disease) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K48/00, A61P, A61P25/00